Bajaj Healthcare Ltd
Pharmaceuticals | Small Cap
Bajaj Healthcare Ltd, operating in the Pharmaceuticals & Biotechnology sector, shows a mixed financial performance. While the company demonstrates strengths in solvency, particularly in managing its debt, it faces challenges in other areas. Growth metrics reveal declines in revenue, operating profit, and net income, alongside a negative trend in earnings per share. Profitability is also a concern, with negative returns on equity and assets. The company's efficiency is hindered by long receivable days and inventory turnover. Despite these weaknesses, Bajaj Healthcare maintains a solid book value per share and manages capital expenditures effectively. The overall financial health appears to be a mix of positive and negative aspects, requiring careful monitoring and strategic adjustments.
Latest Report
View AllLatest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsNeutral
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio1.00
- Financial Ratio2.00
- Profitability Ratio1.00
- Efficiency Ratio1.00
- Coverage Ratio2.00
- Solvency Ratio4.00
- Liquidity Ratio0.00
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentWeak
- 1 HourBullish
- 2 HoursBullish
- 4 HoursBullish
- 1 DayBullish
- 1 WeekNeutral
- 1 MonthBearish
Bajaj Healthcare Ltd, operating in the Pharmaceuticals & Biotechnology sector, shows a mixed financial performance. While the company demonstrates strengths in solvency, particularly in managing its debt, it faces challenges in other areas. Growth metrics reveal declines in revenue, operating profit, and net income, alongside a negative trend in earnings per share. Profitability is also a concern, with negative returns on equity and assets. The company's efficiency is hindered by long receivable days and inventory turnover. Despite these weaknesses, Bajaj Healthcare maintains a solid book value per share and manages capital expenditures effectively. The overall financial health appears to be a mix of positive and negative aspects, requiring careful monitoring and strategic adjustments.
Latest Report
View AllLatest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
Overall Valuation Score
P/E RATIO (TTM)
24.38
Industry Median
19.41
Small Cap Median
18.08
P/E RATIO
28.30
P/B RATIO
2.30
Industry Median
1.98
Small Cap Median
2.03
P/S RATIO
2.06
Industry Median
2.06
Small Cap Median
1.64
Others
PEG RATIO
2.96
EV/EBITDA RATIO
11.30
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹354 as on Feb 20, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
Quarterly Report⬤8th May 26
Statement Of Audited Financial Results For The Quarter And Year Ended On 31 March 2026
UNDEFINED SENTIMENT
The company's growth is poor, with declines in revenue, operating profit, and net income. Earnings per share are also negative. Asset growth is strong, but overall growth is not good. The company needs to focus on strategies to stimulate revenue and profit growth. This might involve exploring new markets, launching new products, or improving operational efficiency.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 3.5 | -5 | -26.78 | 14.8 | 12.52 |
| Operating Profit Growth Rate | -12.5 | -5.88 | -32.14 | 9.21 | 26.51 |
| Earnings Per Share (EPS) Growth | -14.08 | -39.74 | -294.74 | -141.21 | -62.59 |
| Asset Growth Rate | 37.07 | 24.55 | -14.81 | 8.89 | 10.8 |
| Net Income Growth Rate | -14.46 | -39.44 | -295.35 | -147.62 | -60 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The financial performance is weak, with a negative adjusted EPS and low cash EPS. However, the book value per share is strong, and capital expenditures are well-managed. Addressing the negative earnings and dividend trends is crucial to improve overall financial health. Strategies to boost profitability and improve earnings are essential for enhancing financial stability.
| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 25.36 | 15.36 | -14.18 | 12.6 | 13.88 |
| Cash Earnings Per Share (Cash EPS) | 31.79 | 21.43 | -20 | 21.25 | 12.94 |
| Book Value Per Share | 117.5 | 131.43 | 99.64 | 145.62 | 156.76 |
| Dividend Per Share (DPS) | 1.55 | 0.94 | 0.91 | 1 | 0 |
| Capital Expenditures (CapEx) | 79.3 | 93.1 | 19 | 11.4 | 40.5 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The profitability is poor, with negative returns on equity and assets, and low margins. Improving cost management and revenue generation are essential to boost profitability. The company needs to focus on strategies to enhance efficiency and increase margins. This might involve streamlining operations, improving pricing strategies, or reducing overhead costs.
| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | 14.85 | 14.71 | 10.15 | 10.13 | 12.6 |
| Return on Capital Employed (ROCE) | 20 | 14 | 8 | 11 | 11 |
| Return on Equity (ROE) | 21.58 | 11.68 | -30.11 | 8.58 | 3 |
| Return on Assets (ROA) | 16.5 | 12.47 | 9.93 | 9.96 | 11.38 |
| Operating Margin | 17.5 | 17.34 | 16.07 | 15.29 | 17.18 |
| Net Margin | 10.44 | 6.66 | -17.76 | 7.37 | 2.62 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The company's operational efficiency is bad. Inventory turnover is slow, and receivable days are high. This suggests that the company may struggle to convert sales into cash quickly. Optimizing inventory and receivables management is essential to improve cash flow. Efficient use of assets can improve profitability and overall financial health.
| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 2.52 | 1.77 | 1.87 | 2.28 | 2.46 |
| Inventory Turnover Ratio | 4.52 | 2.99 | 2.41 | 3.19 | 2.83 |
| Receivables Turnover Ratio | 4.79 | 3.41 | 2.53 | 2.51 | 2.51 |
| Days Sales in Inventory Ratio | 80.75 | 122.07 | 151.45 | 114.42 | 128.98 |
| Receivable Days | 76.2 | 107.04 | 144.27 | 145.42 | 145.42 |
| Capital Turnover Ratio | 1.72 | 1.4 | 1.48 | 1.02 | 1.02 |
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
The company's coverage is weak. The company faces challenges in meeting its interest obligations. Improving profitability and managing debt levels are essential to strengthen coverage ratios. This can reduce financial risk and improve the company's ability to meet its financial obligations.
| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | 7.92 | 4.22 | -1.87 | 2.54 | 2.05 |
| Equity Dividend Coverage Ratio | 16.67 | 16.67 | 12.5 |
Interest Coverage Ratio
The company's ability to manage long-term debt is good. A high debt-to-equity ratio suggests that the company relies more on equity than debt to finance its assets, indicating lower financial risk. An interest coverage ratio indicates the company's capacity to cover its interest expenses with its earnings. This suggests the company is financially stable and has a lower risk of financial distress.
| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0.17 | 0.21 | 0.13 | 0.12 | 0.11 |
| Debt to Equity Ratio | 0.2 | 0.27 | 0.15 | 0.14 | 0.12 |
| Equity Ratio | 0.83 | 0.79 | 0.87 | 0.88 | 0.89 |
| Debt To Asset Ratio | 0.09 | 0.11 | 0.05 | 0.08 | 0.07 |
Debt Ratio
Debt to Equity Ratio
Interest Coverage Ratio
Liquidity is not good. It might be facing challenges in meeting its short-term obligations. Lower cash ratios could indicate difficulties in quickly converting assets into cash. This situation calls for a close examination of current asset and liability management to ensure the company can efficiently handle its immediate financial needs. Monitoring and optimizing working capital is essential to improve liquidity.
| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 1.22 | 1.17 | 1.13 | 1.96 | 2.04 |
| Quick Ratio | 0.74 | 0.69 | 0.81 | 1.42 | 1.38 |
| Cash Ratio | 0.01 | 0.04 | 0.01 | 0.01 | 0.12 |
| Operating Cash Flow Ratio | 0 | -0.05 | 0.21 | 0.07 | 0.18 |
Current Ratio
Quick Ratio
Cash Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Bajaj Healthcare Ltd | 3.70 | 28.30 | Neutral | 105.00 | 6.33 | 16.00 |
The management effectiveness of Bajaj Healthcare Ltd presents a mixed picture. The company has experienced inconsistent financial performance marked by fluctuating sales and profit growth, particularly a significant downturn in recent periods. While operational efficiency, measured by OPM, has shown some stability, the negative profit growth and concerning financial health indicators such as increasing debt and declining ROCE raise concerns. The reduction in promoter holding further contributes to a cautious outlook on management's strategic direction and alignment with shareholder interests.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Operating Profit Margin | 17% (TTM) | OPM is stable |
| CONS | Sales Growth (3Y) | -10% | Revenue expansion is declining |
| Profit Growth (3Y) | N/A | Profit growth is not sustainable | |
| Return on Capital Employed (Current) | 1.88% | Capital utilization is poor | |
| Promoter Holding (Sep 2024) | 59.19% | Promoter confidence is weak |
Financial Performance & Growth
Bajaj Healthcare Ltd. demonstrates inconsistent financial performance. Compounded Sales Growth shows a declining trend over the past few years. The recent YOY Sales Growth % figures also reflect significant volatility, with some quarters showing positive growth but others showing considerable declines.
| Metric | 2013-2015 | 2016-2018 | 2019-2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Sales Growth % | 13.03% | 15.82% | 28.16% | 3.49% | -5.01% | -26.69% |
The YOY Profit Growth % has been highly variable, with significant negative values in several quarters. This inconsistency poses risks to investor confidence and the company's ability to sustain long-term growth.
| Metric | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| YOY Profit Growth % | -34% | -18% | -25% | 23% | -4% | -36% | -51% | -76% | -67% | 11% | 14% | 63% |
Capital Efficiency & Returns
The company's capital efficiency and returns are concerning. The ROCE % has significantly declined over the years, indicating poor utilization of capital employed. The ROE % is negative, suggesting that shareholder funds are not generating positive returns.
| Metric | 2013-2015 | 2016-2018 | 2019-2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| ROCE % | 10.33% | 15% | 23.33% | 20% | 14% | 8% |
| Metric | 10 Years | 5 Years | 3 Years | Last Year |
|---|---|---|---|---|
| Return on Equity | 13% | 14% | 8% | -12% |
This trend indicates that the company is struggling to generate adequate returns from its investments, potentially leading to decreased investor interest and reduced growth opportunities.
Financial Health & Prudence
Bajaj Healthcare's financial health raises significant concerns. The Debt/Equity Ratio has increased substantially over the years, indicating higher financial leverage. This increased reliance on debt can elevate financial risk and interest expenses.
| Metric | 2013-2015 | 2016-2018 | 2019-2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Debt/Equity Ratio | 2.48 | 0.90 | 0.73 | 0.81 | 1.17 | 1.25 |
The interest coverage ratio, calculated as Operating Profit / Interest, reflects the company's ability to cover its interest obligations. A concerning aspect is the significant increase in interest payments, which could strain profitability.
| Metric | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest | 6 | 7 | 8 | 8 | 8 | 8 | 8 | 7 | 8 | 13 | 18 | 30 |
Shareholding & Ownership Structure
The shareholding pattern reveals some shifts in ownership structure. While promoter holding remained relatively stable until recently, there has been a notable decrease in September 2024. This reduction in promoter holding may indicate a change in confidence or strategic direction.
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Promoters + | 67.26% | 67.26% | 67.26% | 67.26% | 67.26% | 67.26% | 67.49% | 67.74% | 59.19% |
Institutional holding by FIIs and DIIs has seen some fluctuations. The increase in public shareholding indicates a shift in ownership towards retail investors.
| Metric | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public + | 32.42% | 32.36% | 32.38% | 32.62% | 31.30% | 31.38% | 31.48% | 31.22% | 31.06% | 31.31% | 32.27% | 37.77% |
The risk assessment for Bajaj Healthcare Ltd. is flagged as Red due to several concerning factors. The company's segment performance volatility is evident in fluctuating quarterly results, with significant variations in sales and profit growth. Increasing foreign exchange exposure due to substantial import costs, coupled with a rising debt burden and declining profitability, amplifies financial risk. These factors collectively indicate a high-risk profile.
Segment performance volatility
The quarterly results of Bajaj Healthcare reveal significant segment performance volatility. Fluctuations in sales and profit growth indicate instability in the company's operational segments. This variability makes it challenging to predict future performance and increases uncertainty.
| Metric | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| YOY Sales Growth % | -6.03% | 32.93% | -11.79% | 29.43% | -20.89% | -12.29% | -20.79% | -48.18% | -18.10% | -13.11% | 1.93% | 31.50% |
Foreign exchange or interest rate exposure
The company faces increased foreign exchange exposure due to its import activities. The material costs, which constitute a significant portion of the expenses, are influenced by foreign exchange rates. Fluctuations in currency values can impact profitability.
| Metric | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Material Cost % | 71.59% | 76.02% | 62.19% | 62.88% | 51.15% | 58.59% | 57.75% | 44.31% | 47.24% | 62.51% | 49.59% | 49.58% |
Contingent liability evaluation
The company's increasing debt levels and negative profit margins indicate a challenging financial situation. The rise in borrowings to fund operations or expansion increases the company's financial risk profile. This situation requires careful monitoring to ensure the company's ability to meet its financial obligations.
| Metric | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Borrowings - | 72 | 72 | 70 | 81 | 75 | 87 | 81 | 91 | 181 | 257 | 415 | 333 | 206 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10314.67Bullish
- SMA 20311.77Bullish
- SMA 50302.00Bullish
- EMA 10314.04Bullish
- EMA 20311.69Bullish
- EMA 50305.45Bullish
- DEMA 10315.40Bullish
- DEMA 20316.81Bearish
- DEMA 50312.10Bullish
- TEMA 10314.16Bullish
- TEMA 20316.77Bearish
- TEMA 50317.04Bearish
- MACD3.58Bearish
- ADX30.02Strong Trend
- IndicatorValueSignal
- RSI59.63Neutral
- CCI30.86Neutral
- ROC 90.25Bullish
- ROC 145.25Bullish
- ROC 255.48Bullish
- Stoch K56.64Neutral
- Stoch D55.41Neutral
- IndicatorValueSignal
- BB Upper328.22Neutral
- BB Middle311.77Neutral
- BB Lower295.33Neutral
- ATR4.18Low Volatility
- IndicatorValueSignal
- MFI60.05Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10313.00Bullish
- SMA 20307.05Bullish
- SMA 50298.34Bullish
- EMA 10312.25Bullish
- EMA 20307.91Bullish
- EMA 50302.47Bullish
- DEMA 10316.50Bearish
- DEMA 20314.78Bullish
- DEMA 50305.54Bullish
- TEMA 10316.19Bearish
- TEMA 20317.79Bearish
- TEMA 50311.46Bullish
- MACD5.28Bullish
- ADX37.36Strong Trend
- IndicatorValueSignal
- RSI63.44Neutral
- CCI72.64Neutral
- ROC 95.37Bullish
- ROC 144.87Bullish
- ROC 2511.03Bullish
- Stoch K57.18Neutral
- Stoch D57.12Neutral
- IndicatorValueSignal
- BB Upper322.87Neutral
- BB Middle307.05Neutral
- BB Lower291.24Neutral
- ATR5.53Low Volatility
- IndicatorValueSignal
- MFI61.06Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10306.45Bullish
- SMA 20298.46Bullish
- SMA 50297.85Bullish
- EMA 10307.54Bullish
- EMA 20302.89Bullish
- EMA 50302.08Bullish
- DEMA 10314.36Bullish
- DEMA 20307.61Bullish
- DEMA 50298.04Bullish
- TEMA 10317.42Bearish
- TEMA 20313.19Bullish
- TEMA 50N/AN/A
- MACD4.29Bullish
- ADX27.52Strong Trend
- IndicatorValueSignal
- RSI64.21Neutral
- CCI133.56Overbought
- ROC 95.27Bullish
- ROC 148.83Bullish
- ROC 256.87Bullish
- Stoch K74.96Neutral
- Stoch D74.88Neutral
- IndicatorValueSignal
- BB Upper319.21Neutral
- BB Middle298.46Neutral
- BB Lower277.72Neutral
- ATR8.07Low Volatility
- IndicatorValueSignal
- MFI79.05Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10299.09Bullish
- SMA 20299.70Bullish
- SMA 50312.56Bullish
- SMA 100322.45Bearish
- SMA 200378.65Bearish
- EMA 10303.08Bullish
- EMA 20301.82Bullish
- EMA 50309.37Bullish
- EMA 100329.94Bearish
- EMA 200369.69Bearish
- DEMA 10307.45Bullish
- DEMA 20300.06Bullish
- DEMA 50292.68Bullish
- DEMA 100285.62Bullish
- DEMA 200307.28Bullish
- TEMA 10312.01Bullish
- TEMA 20304.51Bullish
- TEMA 50297.94Bullish
- TEMA 100286.93Bullish
- TEMA 200269.67Bullish
- MACD-0.40Bullish
- ADX16.66Weak Trend
- IndicatorValueSignal
- RSI55.99Neutral
- CCI154.75Overbought
- ROC 146.45Bullish
- ROC 256.57Bullish
- Stoch K68.27Neutral
- Stoch D63.75Neutral
- IndicatorValueSignal
- BB Upper315.46Neutral
- BB Middle299.70Neutral
- BB Lower283.95Neutral
- ATR12.45Low Volatility
- IndicatorValueSignal
- MFI61.91Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 20322.14Bearish
- SMA 50395.12Bearish
- EMA 20329.80Bearish
- EMA 50381.23Bearish
- DEMA 20290.26Bullish
- DEMA 50325.34Bearish
- TEMA 20292.43Bullish
- TEMA 50280.39Bullish
- MACD-28.14Bullish
- ADX29.34Strong Trend
- IndicatorValueSignal
- RSI41.07Neutral
- CCI-109.51Oversold
- ROC 14-5.33Bearish
- ROC 25-27.43Bearish
- Stoch K30.69Neutral
- Stoch D28.74Neutral
- IndicatorValueSignal
- BB Upper370.76Neutral
- BB Middle322.14Neutral
- BB Lower273.53Neutral
- ATR31.98Low Volatility
- IndicatorValueSignal
- MFI51.33Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 6334.14Bearish
- SMA 12400.90Bearish
- SMA 24441.49Bearish
- EMA 6338.98Bearish
- EMA 12381.41Bearish
- EMA 24405.94Bearish
- DEMA 6293.09Bullish
- DEMA 12329.30Bearish
- DEMA 24401.72Bearish
- TEMA 6288.90Bullish
- TEMA 12287.13Bullish
- TEMA 24N/AN/A
- MACDN/AN/A
- ADX21.37Weak Trend
- IndicatorValueSignal
- RSI45.98Neutral
- CCI-84.85Neutral
- ROC 25-7.20Bearish
- ROC 50-11.27Bearish
- Stoch K32.01Neutral
- Stoch D50.93Neutral
- IndicatorValueSignal
- BB Upper676.54Neutral
- BB Middle455.75Neutral
- BB Lower234.95Neutral
- ATR84.78Low Volatility
- IndicatorValueSignal
- MFI28.00Neutral